GB202001896D0 - Treatment and prevention of metabolic diseases - Google Patents

Treatment and prevention of metabolic diseases

Info

Publication number
GB202001896D0
GB202001896D0 GBGB2001896.6A GB202001896A GB202001896D0 GB 202001896 D0 GB202001896 D0 GB 202001896D0 GB 202001896 A GB202001896 A GB 202001896A GB 202001896 D0 GB202001896 D0 GB 202001896D0
Authority
GB
United Kingdom
Prior art keywords
prevention
treatment
metabolic diseases
metabolic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2001896.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Singapore Health Services Pte Ltd
Original Assignee
National University of Singapore
Singapore Health Services Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore, Singapore Health Services Pte Ltd filed Critical National University of Singapore
Priority to GBGB2001896.6A priority Critical patent/GB202001896D0/en
Publication of GB202001896D0 publication Critical patent/GB202001896D0/en
Priority to MX2021013356A priority patent/MX2021013356A/en
Priority to PCT/EP2020/062193 priority patent/WO2020225147A1/en
Priority to BR112021021921A priority patent/BR112021021921A2/en
Priority to JP2021564913A priority patent/JP2022531591A/en
Priority to EP20721644.1A priority patent/EP3962936A1/en
Priority to US16/865,259 priority patent/US11813311B2/en
Priority to CA3146344A priority patent/CA3146344A1/en
Priority to AU2020268619A priority patent/AU2020268619A1/en
Priority to CN202080049108.3A priority patent/CN114364693A/en
Priority to KR1020217039250A priority patent/KR20220050087A/en
Priority to TW109114711A priority patent/TW202108606A/en
Priority to CL2021002878A priority patent/CL2021002878A1/en
Ceased legal-status Critical Current

Links

GBGB2001896.6A 2019-05-03 2020-02-12 Treatment and prevention of metabolic diseases Ceased GB202001896D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB2001896.6A GB202001896D0 (en) 2020-02-12 2020-02-12 Treatment and prevention of metabolic diseases
TW109114711A TW202108606A (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
US16/865,259 US11813311B2 (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
PCT/EP2020/062193 WO2020225147A1 (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
BR112021021921A BR112021021921A2 (en) 2019-05-03 2020-05-01 Agent, use of an agent and method of treating or preventing a metabolic disease
JP2021564913A JP2022531591A (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic disorders
EP20721644.1A EP3962936A1 (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
MX2021013356A MX2021013356A (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases.
CA3146344A CA3146344A1 (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
AU2020268619A AU2020268619A1 (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
CN202080049108.3A CN114364693A (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic disorders
KR1020217039250A KR20220050087A (en) 2019-05-03 2020-05-01 Treatment and prevention of metabolic diseases
CL2021002878A CL2021002878A1 (en) 2019-05-03 2021-11-02 Treatment and prevention of metabolic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2001896.6A GB202001896D0 (en) 2020-02-12 2020-02-12 Treatment and prevention of metabolic diseases

Publications (1)

Publication Number Publication Date
GB202001896D0 true GB202001896D0 (en) 2020-03-25

Family

ID=69897115

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2001896.6A Ceased GB202001896D0 (en) 2019-05-03 2020-02-12 Treatment and prevention of metabolic diseases

Country Status (1)

Country Link
GB (1) GB202001896D0 (en)

Similar Documents

Publication Publication Date Title
EP3920923A4 (en) Therapeutic agents and methods of treatment
EP3749264C0 (en) Laser therapy for treatment and prevention of eye diseases
EP4119156A4 (en) Medicament for treatment and/or prevention of cancer
EP4090658A4 (en) Therapeutic agents and methods of treatment
IL280315A (en) Methods of treatment and prevention of alzheimer's disease
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL287802A (en) Compositions and methods for treatment of ocular diseases
EP4058037A4 (en) Fibroblast-based therapy for treatment and prevention of stroke
IL275925A (en) Prevention and treatment of organ fibrosis
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
IL304628A (en) Treatment of skin disorders
GB202002030D0 (en) Treatment and prevention of metabolic diseases
GB202001896D0 (en) Treatment and prevention of metabolic diseases
GB202001013D0 (en) Treatment and prevention of metabolic diseases
EP4099997A4 (en) Methods and compositions for treatment of diseases
GB201906597D0 (en) Treatment and prevention of metabolic diseases
EP4119160A4 (en) Medicament for treatment and/or prevention of cancer
EP4119158A4 (en) Medicament for treatment and/or prevention of cancer
EP4119157A4 (en) Medicament for treatment and/or prevention of cancer
EP4119159A4 (en) Medicament for treatment and/or prevention of cancer
IL270306A (en) Prevention and treatment of pre-myeloid and myeloid malignancies
EP3908370A4 (en) Use of photobiomodulation therapy to treat inflammatory and/or metabolic conditions
EP3863621A4 (en) Combination therapy for treatment and prevention of autoimmune and inflammatory diseases
IL309317A (en) Treatment of mtres1 related diseases and disorders
EP4046658A4 (en) Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)